 from the
endoluminal lining of the post-thrombotic or even the primary diseased vein wall (neovalve) has been reported from
a single site. It has undergone modiÔ¨Åcations over the years,
and recent reports show 85% patency/competency rate
with about 85% healed and ulcer-free recurrence rate at a
mean of 28 months. All valves were patent. There was a
95% ulcer healing rate